Published May 31, 2021 | Version v1
Journal article Open

Correction of urodynamic disorders in women with genitourinary syndrome using a fractional CO2-laser

Creators

  • 1. Bogomolets National Medical University

Description

This article is devoted to the treatment of urodynamic disorders in women with the genitourinary syndrome by using a fractional CO2-laser. Nowdays, the development of genitourinary syndrome is an urgent problem among women of different ages. Genitourinary disorders are a complex of symptoms associated with the development of atrophic and dystrophic processes in the estrogenic tissues (the urethra, lower third of the uterus, pelvic floor ligaments and muscles).
The objective: to determine the pathogenetic effectiveness of CO2 laser in the treatment of urodynamic disorders in premenopausal women with genitourinary syndrome.
Materials and methods. The study covered 130 female patients with symptoms of the genitourinary syndrome. The patients were divided into two groups depending on their treatment. The main group consisted of 56 women using CO2 laser therapy. The comparison group consisted of 74 women who were treated with local application of hormone. To assess the efficacy of treatment and the functional status of the lower urinary tract, a comprehensive pre-treatment and post-treatment urodynamic examination were performed.
Results. The average age of the patients in the examined groups was 47.2±2.5 years. After the treatment, the urodynamic examination showed an increase of the maximal intraurethral pressure from 16.8±17.9 to 26.7±21.2 mm Hg in the main group (p<0.01). The urethral closure pressure increased from 15.3±13.2 to 26.8±18.5 mm Hg (p<0.01). These changes were found upon examination of the functional length of the urethra, which increased from 2.0±0.3 to 3.0±0.4 cm, and thus reached normative values for healthy women. At the same time, the pre-treatment and post-treatment indicators did not statistically differ in comparison group.
Conclusions. The results of the study show that the MonaLisaTouch method of laser fractional ablation of vaginal and vulva epithelium is highly effective compared with local hormonal therapy and can be recommended as a monotherapy for urogenital disorders and pelvic floor dysfunction.

Files

Correction of urodynamic disorders in women with genitourinary syndrome using a fractional CO2-laser.pdf

Files (350.2 kB)

Additional details

References

  • Apolihina I.A., Gorbunova E.A. Clinical and morphological aspects of vulvovaginal atrophy. Medicinskij sovet. 2014; 9: 110-7.
  • Arsent'ev V.G., Sereda Ju.V., Tihonov V.V. and others. Connective tissue dysplasia is the constitutional basis of multiple organ disorders in children and adolescents. Pediatrija. Zhurnal im. G.N. Speranskogo. 2011; 90 (2): 54-7.
  • Balan V.E., Kovaleva L.A. Comprehensive treatment of urogenital atrophy and recurrent urinary tract infections in postmenopause. Jeffektivnaja farmakoterapija. Akusherstvo i ginekologija. 2013; 2 (18): 10-4.
  • Bezmenko A.A., Shmidt A.A., Koval' A.A., Karpishhenko Zh.M. Conservative methods of treatment of urinary incontinence under stress in women. Vestnik Rossijskoj Voenno-medicinnskoj akademii. 2014; 45 (1): 227-32.
  • Gvozd'ov M.Ju., Tupikina N.V., Kasjan G.R., Pushkar D.Ju. Pelvic organ prolapse in the clinical practice of a urologist. Metodychni rekomendacii'. 2016; 2: 22-38.
  • Glazunova A.V., Jureneva S.V. The prevalence of vulvovaginal atrophy and its impact on the quality of life of women. Questions of terminology and safety of local hormone therapy. Akusherstvo i ginekologija. 2014; 11: 29-33.
  • Gorbunova E.A., Apolihina I.A. Atrophic zestoretic as one of the faces genitourinary syndrome. Effektivnaja farmakoterapija. Akusherstvo i ginekologija. 2015; 4 (36): 31-6.
  • Dobrohotova Ju.Je., Ibragimova D.M., Mandrykina Zh.A., Serova L.G. Microbiocenosis of the female genital tract. M.: GEOTAR-Media; 2015. 80 р.
  • Il'ina I.Ju., Dobrohotova Ju.Je., Venediktova M.G., Utina M.S. i soavt. Effective correction of genitourinary menopausal syndrome by laser fractional ablation. RMZh. Mat' i ditja. 2018; 5 (1): 4-8.
  • Il'ina I.Ju., Dobrohotova Ju.Je. Non-surgical methods of correction of genital prolapse and urination disorders. Ginekologija. 2016; 18 (2): 28-31.
  • Il'ina I.Ju., Dobrohotova Ju.Je. Features of urination in gynecological patients. Medicinskij sovet. 2014; 19: 21-25.
  • Kuznecova I.V., Chushkov Ju.V., Ishhenko A.I. The role of local use of estriol in optimizing the outcomes of surgical treatment of genital prolapse in peri – and postmenopausal patients. Akusherstvo i ginekologija. 2015; 19: 2-6.
  • Kulakov V.I., Manuhin I.B., Savel'eva G.M. National guide to gynecology. M.: GEOTAR-Media. 2011: 1120.
  • Leonova Z.A., Florensov V.V. Synthesis and functions of female sex hormones. Sibirskij medicinskij zhurnal. 2013; 117 (2): 10-12.
  • Nejmark A.I., Razdorskaja M.V. Urinary incontinence in women. M.: GEOTAR-Media. 2013: 123.
  • Tumilovich L.G., Gevorkjan M.A. Directory of gynecologistendocrinologist. M.: Prakticheskaja medicina. 2014: 208.
  • Shestakova I.G. Vaginal atrophy in the practice of an obstetrician-gynecologist. Ginekologija. 2014; 6: 7-11.
  • Arroyo C. Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. Int J Womens Health. 2017: 28 (9): 591-5. DOI: 10.2147/IJWH.S136857.
  • Athanasiou S., Pitsouni E., Falagas M.E. et al. CO2 -laser for the genitourinary syndrome of menopause. How many laser sessions? // Maturitas. 2017; 104: 24 –28. DOI: 10.1016/j. maturitas.2017.07.00
  • Behnia-Willison F., Sarraf S., Miller J. et al. Safety and longterm efficacy of fractional CO (2) laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017; 213: 39-44. DOI: 10.1016/j.ejogrb.2017.03.036.
  • Consensus Recommendations. Management of genitourinary syndrome of menopause in women with high risk for breast cancer: consensus recommendations from The North American Monopause Society and the International Society for the Study of Women's Sexual Care. 2018; 25 (6): 1-13. DOI: 10.1097/ GME.0000000000001121
  • Elisabeth A. Erekson, Sallis O. Yip, Terri S. Wedderburn et al. The VSQ: a questionnaire to measure vulvovaginal symptoms in postmenopausal women. Menopause. 2013; 20 (9): 973-9. DOI: 10.1097/GME.0b013e318282600b
  • Fistonić N, Fistonić I, Lukanovič A, Findri Guštek Š, Sorta Bilajac Turina I, Franić D. First assessment of shortterm efficacy of Er: YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015; 18 (1): 37-42. DOI: 10.3109/13697137.2015.1071126.
  • Gambacciani M., Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017; 99: 10 – 15. DOI: 10.1016/j.
  • Gaspar A, Addamo G, Brandi H. Vaginal Fractional CO2 Laser: A Minimally Invasive Option for Vaginal Rejuvenation. Am.J Cosmetic Surg. 2011; 28 (3): 156-62. DOI:10.1177/074880681102800309
  • Management of symptomatic vulvovaginal atrophy: 2013 position statement of The American Menopause Society. Menopause. 2013; 20 (9): 888-902. DOI: 10.1097/ GME.0b013e3182a122c2
  • Moreira A.C, Silva A.M., Santos M.S., Sardao V.A. Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown. J. Steroid BiochemMol.Biol. 2014; 21: 61-71. DOI: 10.1016/j. jsbmb.2014.01.016.
  • Nappi R.E., Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014; 17 (1): 3-9. DOI: 10.3109/13697137.2013.871696
  • Nede O. Williams, Maryam B. Lustberg.. Time for Action: Managing of Genitourinary Syndrome of Menopaues. Journal of Oncology Practice. 2019; 15 (7): 371. DOI 10.1200/ JOP.19.00350
  • Ogrinc U.B., Senear S., Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg. Med. 2015; 47 (9): 689-97. DOI: 10.1002/lsm.22416.
  • Pagano I., Gieri S., Nocera F. et al. Evaluation of the CO2 Laser Therapy on Vulvo-Vaginal Atrophy (VVA) in Oncological Patients: Preliminary Results. J Cancer Ther. 2017; 8 (5): 452-63. DOI: 10.4236/jct.2017.85039.
  • Perino A., Calligaro A., Forlani F. et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015; 80 (3): 296-301. DOI: 10.1016/j. maturitas.2014.12.006.
  • Portman D.J., Gass M.L. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Maturitas. 2014; 79 (3): 349-54. DOI: 10.1016/j. maturitas. 2014.07.013.
  • Rossella E. Nappi, E. Martini, L. Cucinella, S. Martella et al. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Health Aging in Women. Frontiers in Endocrinology. 2019; 10: 1-11. DOI 10.3389/ fendo.2019.00561
  • Stefano S., Stavros A., Massimo C. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol. 2015; 27 (6): 504-8. DOI: 10.1097/ GCO.0000000000000230.